Zydus has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its manufacturing facility located at Pharmez, Ahmedabad from March 20 to 24, 2023, the company announced on Mo0nday through an exchange filing.
The inspection has been classified as Voluntary Action Indicated (VAI). The EIR report indicates that the inspection is closed.
Zydus Shares
The shares of Zydus on Monday at 11:18 am IST were at Rs 590.85, up by 1.34 percent.
India firmly Rejects US Trade Adviser Peter Navarro’s Remarks On Brahmins Profiteering Over Russian Oil Deals
Mining Conglomerate Vedanta Beats Adani Group With ₹17,000 Crore Winning Bid For Acquisition Of Debt-Ridden Jaiprakash Associates
‘Deeply Appreciate And Fully Reciprocate…’: PM Modi’s 1st Reaction To US President Donald Trump’s ‘Will Always Be Friends’ Remark
Bought Tesla To Spread Awareness About Electric Mobility Among Indian Citizens, Especially Youth: Maharashtra Minister
